VNDA
insider transactionsVanda Pharmaceuticals Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$0
41.6K sh
Own +35%
-
Grant·A
Director
$0
41.6K sh
Own +58%
-
Grant·A
SVP, GC and Secretary
$0
80.0K sh
Own +267%
-
Grant·A
Director
$0
41.6K sh
Own +45%
-
Grant·A
Director
$0
41.6K sh
Own +73%
-
Grant·A
Director
$0
41.6K sh
Own +23%
-
Grant·A
Director
$0
41.6K sh
Own +34%
-
Other·G
Director
$0
25.8K sh
Own -27%
-
Grant·A
Director
$0
57.1K sh
Own New
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 4, 2026 | Anne Sempowski Ward | Grant A | 41.6K | $0 |
| Jun 4, 2026 | Stephen Ray Mitchell | Grant A | 41.6K | $0 |
| Jun 4, 2026 | McGuire Daniel Patrick | Grant A | 80.0K | $0 |
| Jun 4, 2026 | Tage Honore | Grant A | 41.6K | $0 |
| Jun 4, 2026 | Charles Cliff Duncan | Grant A | 41.6K | $0 |
| Jun 4, 2026 | Richard W Dugan | Grant A | 41.6K | $0 |
| Jun 4, 2026 | Phaedra Chrousos | Grant A | 41.6K | $0 |
| May 18, 2026 | Stephen Ray Mitchell | Other G | 25.8K | $0 |
| Apr 22, 2026 | Charles Cliff Duncan | Grant A | 57.1K | $0 |
About VNDA insider trading
This page tracks insider transactions for Vanda Pharmaceuticals Inc. (VNDA) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.